Premorbid physical activity predicts disability progression in relapsing-remitting multiple sclerosis

被引:38
|
作者
Motl, Robert W. [1 ]
Dlugonski, Deirdre [1 ]
Pilutti, Lara [1 ]
Sandroff, Brian [1 ]
McAuley, Edward [1 ]
机构
[1] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA
关键词
Exercise; Lifestyle; Disability; Multiple sclerosis; Physiological reserve; NATURAL-HISTORY; IRREVERSIBLE DISABILITY; RISK-FACTORS; EXERCISE; IMPAIRMENT; MODELS; BRAIN;
D O I
10.1016/j.jns.2012.08.033
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Disability progression is a hallmark feature of multiple sclerosis (MS) that has been predicted by a variety of demographic and clinical variables and treatment with disease modifying therapies. This study examined premorbid physical activity as a predictor of change in disability over 24 months in persons with relapsing-remitting MS (RRMS). Methods: 269 persons with RRMS completed baseline measures of demographic and clinical variables, premorbid and current physical activity, and disability status. The measure of disability was further completed every six months over the subsequent 24-month period. The data were analyzed with unconditional and conditional latent growth curve modeling (LGCM). Results: The unconditional LGCM indicated that there was a significant, linear increase in disability scores over time (p=.0015). The conditional LGCM indicated that premorbid physical activity significantly predicted the linear change in disability scores (standardized beta=-.23, p<.005); current physical activity (standardized beta=-.02, p=.81), gender (standardized beta=-.06, p=.54), age (standardized beta=.05, p=.56), duration of MS (standardized beta=.11, p=.15), and treatment with disease modifying therapies (standardized beta=-.03, p=.77) did not predict change in disability scores. Conclusions: The current research highlights the possible role of premorbid physical activity for lessening disability progression over time in persons with RRMS. Additional research is necessary on physical activity initiated after the diagnosis of RRMS as a lifestyle approach for bolstering physiological reserve and preventing disability progression. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:123 / 127
页数:5
相关论文
共 50 条
  • [41] Effect of relapse phenotype on the accumulation of disability in relapsing-remitting multiple sclerosis
    Stewart, T.
    Jokubaitis, V.
    Spelman, T.
    Havrdova, E.
    Horakova, D.
    Trojano, M.
    Izquierdo, G.
    Girard, M.
    Duquette, P.
    Prat, A.
    Lugaresi, A.
    Grammond, P.
    Grand'Maison, F.
    Sola, P.
    Hupperts, R.
    Petersen, T.
    Pucci, E.
    Bergamaschi, R.
    Boz, C.
    Oreja-Guevara, C.
    Lechner-Scott, J.
    Alroughani, R.
    Ramo, C.
    Van Pesch, V.
    Fernandez-Bolanos, R.
    Iuliano, G.
    Rio, M. E.
    Granella, F.
    Slee, M.
    Verheul, F.
    Spitaleri, D. L. A.
    Amato, M. P.
    Hodgkinson, S.
    McCombe, P.
    Cabrera-Gomez, J. A.
    Barnett, M.
    Flechter, S.
    Olascoaga, J.
    Vucic, S.
    Sanchez-Menoyo, J. L.
    Cristiano, E.
    Saladino, M. L.
    Moore, F.
    Gray, O.
    Shuey, N.
    Rozsa, C.
    Singhal, B.
    Shaw, C.
    Butzkueven, H.
    Kalincik, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 726 - 728
  • [42] Oxidative stress is associated with disability in relapsing-remitting multiple sclerosis patients
    Oliveira, S. R.
    Kallaur, A. P.
    Simao, A. N. C.
    Kaimen-Maciel, D. R.
    Lopes, J.
    Panis, C.
    Pereira, W. L. C. J.
    de Andrade, R. M.
    Reiche, E. M. V.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 343 - 343
  • [43] Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis
    Achiron, A
    Barak, Y
    Rotstein, Z
    [J]. MULTIPLE SCLEROSIS, 2003, 9 (05): : 486 - 491
  • [44] No evidence for CCVSI in relapsing-remitting multiple sclerosis patients with moderate disability
    Juenemann, Martin
    Yeniguen, Mesut
    Stolz, Erwin
    Berghoff, Martin
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 (09) : 2409 - 2410
  • [45] Rituximab in relapsing-remitting multiple sclerosis
    Schrijver, Hans M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24): : 2645 - 2645
  • [46] Fingolimod for relapsing-remitting multiple sclerosis
    La Mantia, Loredana
    Tramacere, Irene
    Firwana, Belal
    Pacchetti, Ilaria
    Palumbo, Roberto
    Filippini, Graziella
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [47] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [48] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Zhou, Hongyu
    Han, Wenjie
    Zhang, Shihong
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [49] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    [J]. NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [50] Fatigue predicts disease worsening in relapsing-remitting multiple sclerosis patients
    Cavallari, Michele
    Palotai, Miklos
    Glanz, Bonnie I.
    Egorova, Svetlana
    Prieto, Juan Carlos
    Healy, Brian C.
    Chitnis, Tanuja
    Guttmann, Charles R. G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (14) : 1841 - 1849